Caspase-9 activation in hypoxic human corneal epithelial cells

Apoptosis

Volumn 8, Issue 6, 2003, Pages 681-688

  Kurpakus Wheater, M ^a,b   Sexton, R ^a   McDermott, M L ^a   Mrock, L K ^a   Sosne, G ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase; Cornea; Epithelium; Fas; Hypoxia

Indexed keywords

CASPASE 8; CASPASE 9; FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; CORNEA EPITHELIUM; DENSITOMETRY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LOSS; GENE REPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANOXIA; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; CORNEA; EPITHELIAL CELLS; HUMANS;

EID: 0242467923     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026164332473     Document Type: Article

References (34)

1. Martin SJ, Green DR. Protease activation during apoptosis: Death by a thousand cuts? Cell 1995; 82: 349-352.
2. Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem Sci 1997; 22: 299-306.
3. Bratton SB, MacFarlane M, Cain K, Cohen GM. Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp Cell Res 2000; 256: 27-33.
4. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, et al. Molecular ordering of the Fas-apoptotic pathway. The Fas/APO-1 protease Mch5 is a Crm-A-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996; 93: 14486-14491.
5. Medema JP, Scaffidi C, Kischkel FC, et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997; 16: 294-2804.
6. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11: 255-260.
7. Kruidering M, Evan GI. Caspase-8 in apoptosis: The beginning of "the end"? IUBMB Life 2000; 50: 85-90.
8. Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-195.
9. Tschopp J, Irmler M, Thome M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 1998; 10: 552-558.
10. Guiet C, Silvestri E, De Smaele E, Franzoso G, Vito P. c-FLIP efficiently rescues TRAF-2 -/- cells from TNF-induced apoptosis. Cell Death Differ 2002; 9: 138-142.
11. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
12. Sun XM, MacFarlane M, Zhuang J, et al. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 1999; 274: 5053-5060.
13. Grossman J, Walther K, Artinger M, Klessing S, Scholmerich J. Apoptosis signaling during initiation of detachment-induced apoptosis ("anoikis" ) of primary human intestinal epithelial cells. Cell Growth & Differ 2001; 12: 147-155.
14. Chae HJ, Kim SC, Han KS, et al. Hypoxia induces apoptosis by caspase activation accompanying cytochrome c release from mitochondria in MC3T3E1 osteoblasts. p38 MAPK is related in hypoxia-induced apoptosis. Immunopharmacol Immunotoxicol 2001; 23: 133-152.
15. Alarcon RM, Denko NC, Giaccia AJ. Genetic determinants that influence hypoxia-induced apoptosis. Novartis Found Symp 2001; 240: 115-128.
16. Hirai K, Sugawara T, Chan PH, et al. Cytochrome c associated apoptosis during ATP recovery after hypoxia in neonatal rat cerebrocortical slices. J Neurochem 2002; 83: 309-319.
17. Khurana P, Ashraf QM, Mishra OP, Delivoria-Papadopoulos M. Effect of hypoxia on caspase-3, -8, and -9 activity and expression in the cerebral cortex of newborn piglets. Neurochem Res 2002; 27: 931-938.
18. Esco MA, Hazlett LD, Kurpakus-Wheater M. Pseudomonas aeruginosa binds to extracellular matrix deposited by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2002; 43: 3654-3659.
19. Wang Z, Kurpakus-Wheater M. Decreased plasminogen activator inhibitor-1 secretion in hypoxic corneal epithelial cells results in increased urokinase plasminogen activator activity. Int J Biochem & Cell Biol 2003; 35: 339-348.
20. Heinkel AW, Bieger SC. Quantification of proteins dissolved in an electrophoresis sample buffer. Anal Biochem 1994; 223: 329-331.
21. Bossenmeyer-Pourie C, Daval JL. Prevention from hypoxia-induced apoptosis by pre-conditioning: A mechanistic approach in cultured neurons from fetal rat forebrain. Brain Res Mol Brain Res 1997; 58: 237-239.
22. Volm M, Mattern J, Koomagi R. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinoma. Anticancer Res 1999; 19: 1669-1671.
23. Sabatti C, Karsten SL, Geschwind DH. Thresholding rules for recovering a sparse signal from microarray experiments. Math Biosci 2002; 176: 17-34.
24. Tsibris JC, Segars J, Coppola D, et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 2002; 78: 114-121.
25. Zimmerman KC, Bonzon C, Green DR. The machinery of programmed cell death. Pharm & Therap 2001; 92: 57-70.
26. Faris M, Larinis KM, Kempiak SH, Koretzky GA, Nel A. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. Mol Cell Biol 1998; 18: 5414-5424.
27. Mohan RR, Liang Q, Kim WJ, Helena MC, Baerveldt F, Wilson SE. Apoptosis in the cornea: Further characterization of Fas/Fas ligand system. Exp Eye Res 1997; 65: 575-589.
28. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res 1999; 18: 293-309.
29. Niederkorn JY. The immune privilege of corneal allografts. Transplantation 1999; 27: 1503-1508.
30. Sano Y, Yamada J, Ishino Y, et al. Non-cleavable mutant Fas ligand transfection of donor cornea abrogates ocular immune privilege. Exp Eye Res 2002; 75: 475-483.
31. Nishigaki K, Minatogucki S, Seishima M, et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 1997; 29: 1214-1220.
32. Mogi M, Fukuo K, Yang J, Suhara T, Ogihara T. Hypoxia stimulates release of the soluble forma of Fas ligand that inhibits endothelial cell apoptosis. Lab Invest 2001; 81: 177-184.
33. Tanaka M, Irai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998; 4: 31-36.
34. Aoki K, Kurooka M, Chen JJ, Petryniak J, Nabel EG, Nabel GJ. Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity. Nat Immunol 2001; 2: 333-337.